NCT01727076 2017-09-15
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Completed
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)